Bicara Therapeutics Inc. (BCAX) vs Oric Pharmaceuticals, Inc. (ORIC)
Bicara Therapeutics Inc. and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Bicara Therapeutics Inc. and Oric Pharmaceuticals, Inc. are of similar size ($1.4B and $1.3B). Across the 9 metrics below, Oric Pharmaceuticals, Inc. leads on 6 and Bicara Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | BCAX | ORIC | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (41.01%) | (39.80%) | (57.72%) |
| Return on assets | (38.38%) | (37.35%) | (49.22%) |
| Return on invested capital | 0.00% | (83.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack